Go Back Go Back
Go Back Go Back
Go Back Go Back

Health Facility Assessment On Availability of Reproductive Health Commodities and Services in Sierra Leone, 2019

  Health Facility Assessment On Availability of Reproductive Health Commodities and Services in Sierra Leone, 2019
  Health Facility Assessment On Availability of Reproductive Health Commodities and Services in Sierra Leone, 2019

Publisher

Number of pages

154

Author

UNFPA Sierra Leone

Annual Report

Health Facility Assessment On Availability of Reproductive Health Commodities and Services in Sierra Leone, 2019

Publication date

11 August 2020

Download Icon

The Government of Sierra Leone (GoSL) has instituted the Basic Package of Essential Health Services that aims to establish a high-impact, cost-effective primary healthcare service delivery mechanism and scale up health services including sexual and reproductive health services and child and maternal health services. As part of UNFPA’s support to the GoSL in the realization of universal access to sexual and reproductive health services, the National Health Facility Assessment on Availability of Reproductive Health Commodities and Services is conducted on a yearly basis to provide up-to-date information on the availability of Family planning (FP) supplies and life-saving maternal and RH medicines in the country.

The survey is designed to provide an overall picture of the availability and level of stock-outs, assess relevant aspects of health facility resources, clients’ perception about the quality of FP services and their appraisal of costs incurred to access the services. Specifically, the 2019 survey focused on generating the following key indicators:

  • percentage of primary Service Delivery Points (SDPs) with at least three (3) modern contraceptive methods;
  • percentage of SDPs providing delivery services where at least seven (7) life-saving maternal/RH medicines (including two mandatory medicines) from the World Health Organization (WHO) list are available; and
  • percentage of SDPs with ‘no stock-out’ of contraceptives within the last three months before the survey.